Migraine is one of the most common neurologic disorders with a global prevalence of approximately 15%, representing over one billion individuals. Migraine results in substantial disability and financial cost; and is the most disabling disorder under age 50 years. While migraine has been recognized since ancient times, the last few years have witnessed substantial advances in the understanding of the pathophysiology and treatment of this disorder. This volume will cover effective treatment of migraine, including different subtypes of migraine and in different patient populations. The classification and diagnostic criteria of common and uncommon subtypes of migraine will be explored in detail, including childhood variants. An in-depth analysis of the pharmacology of acute and prophylactic agents will be presented and an evidence-based review of pharmacologic management will be provided. This will include the recently developed CGRP monoclonal antibodies and non-peptide small molecule CGRP antagonists. Advances in neuromodulatory treatments, both noninvasive and implantable, will be critically reviewed. Specific treatment-related issues in pregnancy and lactation and childhood as well as the elderly will be covered. Issues related to the diagnosis and management of vestibular migraine and the co-morbid disorder of persistent postural-perceptual dizziness will be explored. In summary, this volume will provide a detailed, comprehensive coverage of contemporary treatment of migraine. Summarizes evidence-based best treatment for migraineDifferentiates treatment based on patient population, migraine type, and clinical settingIncludes pharmacological, biobehavioral, and physical treatmentsIncludes specialized treatment for children, the elderly, and pregnant patients | Migraine Management by Jerry W. Swanson, Hardcover | Indigo Chapters